Research map: Why Has Prostate Cancer Research Lagged Behind? Advocacy, Biology, and the Road Ahead

Back to the article

Papers in this map

  1. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer · Philip W. Kantoff · 2010 · 5588 citations · Cited by this paper
  2. Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · 2026 · Related
  3. Tertiary lymphoid structures in the era of cancer immunotherapy · Catherine Sautès‐Fridman · 2019 · 1917 citations · Cited by this paper
  4. The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · 2026 · Related
  5. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study · Emmanuel S. Antonarakis · 2019 · 743 citations · Cited by this paper
  6. Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · 2026 · Related
  7. CELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 1 · Richard E. Sobel · 2005 · 362 citations · Cited by this paper
  8. Exploration of the Challenges in the Management of Prostate Cancer in East Africa · 2025 · Related
  9. The role of masculinities in psychological and emotional help seeking by men with prostate cancer · Belinda C. Goodwin · 2019 · 31 citations · Cited by this paper
  10. Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study · 2026 · Related
  11. Breast cancer activism: past lessons, future directions · Barron H. Lerner · 2002 · 23 citations · Cited by this paper
  12. Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · 2026 · Related
  13. Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer · Caipeng Qin · 2022 · 23 citations · Cited by this paper
  14. Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) · 2026 · Related
  15. Understanding and Addressing Prostate Cancer Disparities in Diagnosis, Treatment, and Outcomes Among Black Men · Anastasia Murphy · 2024 · 13 citations · Cited by this paper
  16. Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · 2026 · Related
  17. Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer · Mohammed Shahait · 2024 · 11 citations · Cited by this paper
  18. A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer · 2025 · Related
  19. Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer · Marco Antonio De Velasco · 2024 · 9 citations · Cited by this paper
  20. Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules · 2025 · Related
  21. Trend in cancer incidence in Mato Grosso and its health regions, Brazil, 2001–2018 · Marco Aurélio Bertúlio das Neves · 2025 · 3 citations · Cited by this paper
  22. Incidence, Mortality, and Federal Research Funding by Cancer Type in the US · Chirayu Mohindroo · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)